A detailed history of Page Arthur B transactions in Johnson & Johnson stock. As of the latest transaction made, Page Arthur B holds 21,350 shares of JNJ stock, worth $3.08 Million. This represents 3.52% of its overall portfolio holdings.

Number of Shares
21,350
Previous 22,580 5.45%
Holding current value
$3.08 Million
Previous $3.54 Million 4.58%
% of portfolio
3.52%
Previous 3.75%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$155.22 - $162.74 $190,920 - $200,170
-1,230 Reduced 5.45%
21,350 $3.38 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $204,713 - $223,385
-1,406 Reduced 5.86%
22,580 $3.54 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $22,583 - $25,299
-145 Reduced 0.6%
23,986 $3.74 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $187,843 - $202,155
-1,217 Reduced 4.8%
24,131 $3.99 Million
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $3,021 - $3,605
-20 Reduced 0.08%
25,348 $3.93 Million
Q4 2022

Feb 08, 2023

SELL
$160.2 - $179.79 $39,249 - $44,048
-245 Reduced 0.96%
25,368 $4.48 Million
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $63,886 - $71,089
-396 Reduced 1.52%
25,613 $4.18 Million
Q2 2022

Jul 19, 2022

SELL
$168.19 - $186.01 $134,888 - $149,180
-802 Reduced 2.99%
26,009 $4.62 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $153,870 - $174,741
-973 Reduced 3.5%
26,811 $4.75 Million
Q4 2021

Feb 08, 2022

SELL
$155.93 - $173.01 $55,355 - $61,418
-355 Reduced 1.26%
27,784 $4.75 Million
Q3 2021

Nov 10, 2021

SELL
$161.5 - $179.47 $127,585 - $141,781
-790 Reduced 2.73%
28,139 $4.55 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $6,379 - $6,842
-40 Reduced 0.14%
28,929 $4.77 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $29,542 - $32,902
-193 Reduced 0.66%
28,969 $4.76 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $31,809 - $36,512
232 Added 0.8%
29,162 $4.59 Million
Q3 2020

Oct 28, 2020

SELL
$140.38 - $153.83 $6,317 - $6,922
-45 Reduced 0.16%
28,930 $4.31 Million
Q2 2020

Jul 28, 2020

SELL
$128.81 - $155.51 $200,299 - $241,818
-1,555 Reduced 5.09%
28,975 $4.08 Million
Q1 2020

May 07, 2020

BUY
$111.14 - $153.99 $28,118 - $38,959
253 Added 0.84%
30,530 $4 Million
Q4 2019

Jan 15, 2020

SELL
$127.5 - $146.44 $225,547 - $259,052
-1,769 Reduced 5.52%
30,277 $4.42 Million
Q3 2019

Nov 04, 2019

SELL
$126.95 - $142.14 $68,553 - $76,755
-540 Reduced 1.66%
32,046 $4.15 Million
Q2 2019

Jul 24, 2019

SELL
$131.15 - $144.24 $348,990 - $383,822
-2,661 Reduced 7.55%
32,586 $4.54 Million
Q1 2019

Apr 29, 2019

SELL
$125.72 - $139.79 $173,242 - $192,630
-1,378 Reduced 3.76%
35,247 $4.93 Million
Q4 2018

Jan 24, 2019

SELL
$122.84 - $147.84 $75,669 - $91,069
-616 Reduced 1.65%
36,625 $4.73 Million
Q3 2018

Oct 15, 2018

SELL
$121.58 - $142.88 $85,106 - $100,016
-700 Reduced 1.84%
37,241 $5.15 Million
Q2 2018

Jul 30, 2018

SELL
$119.4 - $131.76 $164,413 - $181,433
-1,377 Reduced 3.5%
37,941 $4.6 Million
Q1 2018

Apr 24, 2018

SELL
$125.1 - $148.14 $169,135 - $200,285
-1,352 Reduced 3.32%
39,318 $5.04 Million
Q4 2017

Feb 02, 2018

SELL
$131.22 - $143.62 $280,942 - $307,490
-2,141 Reduced 5.0%
40,670 $5.68 Million
Q3 2017

Oct 26, 2017

BUY
$129.47 - $135.38 $5.54 Million - $5.8 Million
42,811
42,811 $5.57 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Page Arthur B Portfolio

Follow Page Arthur B and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Page Arthur B, based on Form 13F filings with the SEC.

News

Stay updated on Page Arthur B with notifications on news.